Artículos con órdenes de acceso público - Michael S. LawrenceMás información
No disponibles en ningún lugar: 3
Revisar
SHP2 inhibition restores sensitivity in ALK-rearranged non-small-cell lung cancer resistant to ALK inhibitors
L Dardaei, HQ Wang, M Singh, P Fordjour, KX Shaw, S Yoda, G Kerr, ...
Nature medicine 24 (4), 512-517, 2018
Órdenes: US National Institutes of Health, Wellcome Trust
Revisar
Antibody-peptide epitope conjugates for personalized cancer therapy
S Zhang, C Yan, DG Millar, Q Yang, JM Heather, A Langenbucher, ...
Cancer Research 82 (5), 773-784, 2022
Órdenes: US National Institutes of Health, Alex's Lemonade Stand
Revisar
1314 RECURRENT MUTATIONS IN SPOP DEFINE A DISTINCT MOLECULAR CLASS OF PROSTATE CANCER
C Barbieri, S Baca, F Demichelis, M Lawrence, M Blattner, JP Theurillat, ...
The Journal of Urology 187 (4S), e532-e533, 2012
Órdenes: US National Institutes of Health
Disponibles en algún lugar: 202
Revisar
Comprehensive molecular portraits of human breast tumours
Brigham & Women’s Hospital & Harvard Medical School Chin Lynda 9 11 Park ...
Nature 490 (7418), 61-70, 2012
Órdenes: US National Institutes of Health
Revisar
Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1
RGW Verhaak, KA Hoadley, E Purdom, V Wang, Y Qi, MD Wilkerson, ...
Cancer cell 17 (1), 98-110, 2010
Órdenes: US National Institutes of Health
Revisar
Comprehensive molecular characterization of human colon and rectal cancer
Cancer Genome Atlas Network
Nature 487 (7407), 330, 2012
Órdenes: US National Institutes of Health
Revisar
Comprehensive genomic characterization defines human glioblastoma genes and core pathways
Cancer Genome Atlas Research Network Tissue source sites: Duke University ...
Nature 455 (7216), 1061-1068, 2008
Órdenes: US National Institutes of Health
Revisar
Integrated genomic analyses of ovarian carcinoma
Cancer Genome Atlas Research Network
Nature 474 (7353), 609, 2011
Órdenes: US National Institutes of Health
Revisar
Mutational heterogeneity in cancer and the search for new cancer-associated genes
MS Lawrence, P Stojanov, P Polak, GV Kryukov, K Cibulskis, ...
Nature 499 (7457), 214-218, 2013
Órdenes: US National Institutes of Health, Howard Hughes Medical Institute
Revisar
Comprehensive molecular characterization of gastric adenocarcinoma
Cancer Genome Atlas Research Network
Nature 513 (7517), 202, 2014
Órdenes: US National Institutes of Health
Revisar
The somatic genomic landscape of glioblastoma
CW Brennan, RGW Verhaak, A McKenna, B Campos, H Noushmehr, ...
cell 155 (2), 462-477, 2013
Órdenes: US National Institutes of Health, Howard Hughes Medical Institute
Revisar
Integrated genomic characterization of endometrial carcinoma
DA Levine, ...
Nature 497 (7447), 67-73, 2013
Órdenes: US National Institutes of Health
Revisar
Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples
K Cibulskis, MS Lawrence, SL Carter, A Sivachenko, D Jaffe, C Sougnez, ...
Nature biotechnology 31 (3), 213-219, 2013
Órdenes: US National Institutes of Health
Revisar
The immune landscape of cancer
V Thorsson, DL Gibbs, SD Brown, D Wolf, DS Bortone, THO Yang, ...
Immunity 48 (4), 812-830. e14, 2018
Órdenes: US Department of Defense, US National Institutes of Health
Revisar
The landscape of somatic copy-number alteration across human cancers
R Beroukhim, CH Mermel, D Porter, G Wei, S Raychaudhuri, J Donovan, ...
Nature 463 (7283), 899-905, 2010
Órdenes: US National Institutes of Health, Howard Hughes Medical Institute
Revisar
Comprehensive molecular profiling of lung adenocarcinoma
Cancer Genome Atlas Research Network
Nature 511 (7511), 543, 2014
Órdenes: US National Institutes of Health, Howard Hughes Medical Institute
Revisar
Comprehensive genomic characterization of squamous cell lung cancers
Cancer Genome Atlas Research Network
Nature 489 (7417), 519, 2012
Órdenes: US National Institutes of Health
Revisar
Discovery and saturation analysis of cancer genes across 21 tumour types
MS Lawrence, P Stojanov, CH Mermel, JT Robinson, LA Garraway, ...
Nature 505 (7484), 495-501, 2014
Órdenes: US National Institutes of Health, Howard Hughes Medical Institute
Revisar
Somatic mutations affect key pathways in lung adenocarcinoma
L Ding, G Getz, DA Wheeler, ER Mardis, MD McLellan, K Cibulskis, ...
Nature 455 (7216), 1069-1075, 2008
Órdenes: US National Institutes of Health
Revisar
A landscape of driver mutations in melanoma
E Hodis, IR Watson, GV Kryukov, ST Arold, M Imielinski, JP Theurillat, ...
Cell 150 (2), 251-263, 2012
Órdenes: Swiss National Science Foundation, US National Institutes of Health …
La información de publicación y financiación se determina de forma automática mediante un programa informático